1.
Obstetrical Mode of Delivery and Childhood Behavior and Psychological Development in a British Cohort
by Curran, Eileen A
Journal of autism and developmental disorders, 2015-09-28, Vol.46 (2), p.603-614
2.
Neonatal adiposity increases the risk of atopic dermatitis during the first year of life
by O'Donovan, Sinéad M., PhD
Journal of allergy and clinical immunology, 2015, Vol.137 (1), p.108-117
3.
Thin-for-gestational age infants are at increased risk of neurodevelopmental delay at 2 years
by O'Neill, Sinéad M
Archives of disease in childhood. Fetal and neonatal edition, 2017-05, Vol.102 (3), p.F197-F202
4.
Low vitamin D deficiency in Irish toddlers despite northerly latitude and a high prevalence of inadequate intakes
by ní Chaoimh, Carol
European journal of nutrition, 2016-12-26, Vol.57 (2), p.783-794
5.
Inhibition of Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Protects Against Plasma-Mediated Vascular Dysfunction Associated With Pre-Eclampsia
by English, Fred A
American journal of hypertension, 2013-02, Vol.26 (2), p.279-286
6.
Exploration and confirmation of factors associated with uncomplicated pregnancy in nulliparous women: prospective cohort study
by Chappell, Lucy C
British journal of sports medicine, 2015-01, Vol.49 (2), p.136-136
7.
Early Pregnancy Prediction of Preeclampsia in Nulliparous Women, Combining Clinical Risk and Biomarkers: The Screening for Pregnancy Endpoints (SCOPE) International Cohort Study
by KENNY, Louise C
Hypertension (Dallas, Tex. 1979), 2014, Vol.64 (3), p.644-652
8.
Robust Early Pregnancy Prediction of Later Preeclampsia Using Metabolomic Biomarkers
by Kenny, Louise C
Hypertension (Dallas, Tex. 1979), 2010-10, Vol.56 (4), p.741-749
9.
Peroxisome Proliferator-Activated Receptor-γ as a Potential Therapeutic Target in the Treatment of Preeclampsia
by McCarthy, Fergus P
Hypertension (Dallas, Tex. 1979), 2011-08, Vol.58 (2), p.280-286
10.
Evidence Implicating Peroxisome Proliferator-Activated Receptor-γ in the Pathogenesis of Preeclampsia
by McCarthy, Fergus P
Hypertension (Dallas, Tex. 1979), 2011-11, Vol.58 (5), p.882-887
11.
Integrated Proteomics Pipeline Yields Novel Biomarkers for Predicting Preeclampsia
by Myers, Jenny E
Hypertension (Dallas, Tex. 1979), 2013-06, Vol.61 (6), p.1281-1288
12.
Plasma-Mediated Vascular Dysfunction in the Reduced Uterine Perfusion Pressure Model of Preeclampsia: A Microvascular Characterization
by Walsh, Sarah K
Hypertension (Dallas, Tex. 1979), 2009-08, Vol.54 (2), p.345-351
13.
Body Composition within the First 3 Months: Optimized Correction for Length and Correlation with BMI at 2 Years
by Hawkes, Colin P
Hormone research in paediatrics, 2016-10, Vol.86 (3), p.178-187
14.
Thin-for-gestational age infants are at increased risk of neurodevelopmental delay at 2years
by O'Neill, Sinead M
Archives of disease in childhood. Fetal and neonatal edition, 2017-05-19, Vol.102 (3), p.F197-F202
15.
Autonomic dysfunction in dementia
by Allan, L M
Journal of neurology, neurosurgery and psychiatry, 2007-07, Vol.78 (7), p.671-677
16.
Phenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistance
by SMITH, Robert A
AIDS (London), 2011, Vol.25 (18), p.2235-2241
18.
Effects of cyclooxygenase and lipoxygenase inhibition on eicosanoids and healing of acetic acid colitis in rats
by LEDUC, L. E
Digestive diseases and sciences, 1993, Vol.38 (2), p.289-294
